This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in Amsterdam

Sarah Touw-Mercier, Remote
Senior Scientist, USP at Janssen, Pharmaceutical Companies of Johnson and Johnson


Sarah Touw-Mercier is a Senior Scientist in the upstream process development group of Janssen Vaccines & Prevention, where she works on late stage process development, process validation and regulatory submissions of Adenovirus-based vaccines. She joined Janssen (former Crucell) in 2009 and enrolled in a PhD program in 2010 in collaboration with the University of Wageningen (the Netherlands), where she applied the principles of Process Analytical Technology (PAT) and Quality by Design (QbD) on a PER.C6® perfusion cell cultivation process. Prior to joining Janssen, Sarah worked at Genentech in South San Francisco (USA) in the Late Stage Cell Culture group.

Agenda Sessions

  • PAT for vaccine manufacturing: integrated upstream and downstream applications